ProShare Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $794K | Sell |
|
|||||
|
2025
Q1 | $886K | Sell |
|
|||||
|
2024
Q4 | $1.07M | Buy |
|
|||||
|
2024
Q3 | $1.26M | Buy |
|
|||||
|
2024
Q2 | $701K | Sell |
|
|||||
|
2024
Q1 | $482K | Buy |
|
|||||
|
2023
Q4 | $154K | Buy |
|
|||||
|
2023
Q3 | $89.5K | Buy |
|
|||||
|
2023
Q2 | $153K | Buy |
|
|||||
|
2023
Q1 | $193K | Buy |
|
|||||
|
2022
Q4 | $253K | Buy |
|
|||||
|
2022
Q3 | $164K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $221K | Sell |
|
|||||
|
2021
Q4 | $353K | Buy |
|
|||||
|
2021
Q3 | $359K | Sell |
|
|||||
|
2021
Q2 | $361K | Buy |
|
|||||
|
2021
Q1 | $290K | Buy |
|
|||||
|
2020
Q4 | $242K | Buy |
|